Mark Oldroyd
Mr. Oldroyd has spent over 26 years in the healthcare industry. His primary focus has been on startup organizations, building and executing business development and commercial strategies for new assets in therapeutics, diagnostics, real world data/AI engineering and software. His expertise involves finding the best business use cases to generate revenue for new products in a large and challenging healthcare ecosystem. He is currently the Chief Business Officer at C2i Genomics and sits on the Board of Directors at Base 10 Genetics. Additionally, Mr. Oldroyd consults or advises a number of startup and larger organizations within the digital health, data security and diagnostic industries. His education includes a Juris Doctor with a specialty in health law and policy. Mr. Oldroyd spends much of his free time with his five adult children and two grandsons. His other interests include aviation, as a private pilot, and adventure motorcycling.